NKTX Competitors & Alternatives
Compare Nkarta Inc with similar stocks in the same industry
Biotechnology
NKTX
Main Stock$3.03
Tradestie Score
58
Market Cap
$151.28M
Analyst Upside
+269.6%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.43
|
$258.18M | - | 53 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$30.86
|
$256.54M | - | 61 | Compare |
|
BDTX
Black Diamond Therapeutics, Inc. Common Stock
|
$1.61
|
$211.80M | - | 48 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$9.07
|
$211.22M | - | 56 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.92
|
$202.58M | - | 59 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$26.80
|
$188.81M | 326.3 | 53 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$17.83
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.01
|
$158.43M | - | 53 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$4.22
|
$153.02M | - | 60 | Compare |
More NKTX Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry